AtriCure (ATRC) Cash from Financing Activities (2016 - 2025)
AtriCure (ATRC) has disclosed Cash from Financing Activities for 16 consecutive years, with $2.1 million as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities rose 20.71% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 132.64% year-over-year, with the annual reading at $1.2 million for FY2025, 132.64% up from the prior year.
- Cash from Financing Activities for Q4 2025 was $2.1 million at AtriCure, down from $6.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $6.0 million in Q3 2025, with the low at -$10.7 million in Q1 2021.
- Average Cash from Financing Activities over 5 years is -$858000.0, with a median of $1.8 million recorded in 2022.
- The sharpest move saw Cash from Financing Activities tumbled 650.83% in 2021, then skyrocketed 1897.0% in 2025.
- Over 5 years, Cash from Financing Activities stood at $2.5 million in 2021, then decreased by 20.94% to $2.0 million in 2022, then rose by 19.02% to $2.4 million in 2023, then dropped by 26.32% to $1.7 million in 2024, then increased by 20.71% to $2.1 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods came in at $2.1 million, $6.0 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.